Area of research
Infectious Diseases · Virology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, HIV Research and Treatment, HIV/AIDS drug development and treatment, and SARS-CoV-2 detection and testing.
Low reticulocyte count at infusion is a risk factor for ICANS in CAR-T cell therapy
APOBEC3B Does Not Promote Tumor Progression in Tp53 Hemizygous Mice.
APOBEC3B Does Not Promote Tumor Progression in Tp53 Hemizygous Mice
Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants.
Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant.
Multiple mutations of SARS-CoV-2 Omicron BA.2 variant orchestrate its virological characteristics.
HTLV-1 bZIP factor impairs DNA mismatch repair system
Determination of the factors responsible for host tropism of SARS-CoV-2-related bat coronaviruses
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity.
Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant.
Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation.
Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike.
Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5.
The SARS-CoV-2 Lambda variant exhibits enhanced infectivity and immune resistance
Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant.
The SARS-CoV-2 spike S375F mutation characterizes the Omicron BA.1 variant.
A panel of nanobodies recognizing conserved hidden clefts of all SARS-CoV-2 spike variants including Omicron.
Monitoring fusion kinetics of viral and target cell membranes in living cells using a SARS-CoV-2 spike-protein-mediated membrane fusion assay.
Characterization of the Immune Resistance of Severe Acute Respiratory Syndrome Coronavirus 2 Mu Variant and the Robust Immunity Induced by Mu Infection.
Virological characteristics of SARS-CoV-2 BA.2 variant
Convergent evolution of the SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant
Virological characteristics of the SARS-CoV-2 Omicron BA.2.75
ILF2 enhances the DNA cytosine deaminase activity of tumor mutator APOBEC3B in multiple myeloma cells.
Intratracheal trimerized nanobody cocktail administration suppresses weight loss and prolongs survival of SARS-CoV-2 infected mice.
Pharmacologic characterization of TBP1901, a prodrug form of aglycone curcumin, and CRISPR-Cas9 screen for therapeutic targets of aglycone curcumin.
SARS-CoV-2 spike S375F mutation characterizes the Omicron BA.1 variant
Intratracheal trimerized nanobody cocktail protects against SARS-CoV-2 Omicron in mice
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion.
Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation